
Thermo Fisher Scientific Inc.
TMO 669.54 (-2.79%) 18.67
EV: $325.48(B)
Total Equity: $54.90(B)
Debt/Equity: 0.75
Dividend/share: $1.8
Div. yield: 0.27%
P/E: 35.20
Forward P/E: 26.48
P/FCF: 32.66
P/S: 5.26
P/B: 4.53
EPS: $19.0
EPS (fwd): $25.3
FCF/share: $20.5
Revenue/share: $127.4
Book value/share: $147.8
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Margins: Gross | Op. | Net
41.3% | 18.4% | 14.9%
0.0%of Portfolio
My holdings
Day change
Total change
5Y Shares Out Change < 0% Debt/Equity < 1 Current Ratio > 1 Quick Ratio > 1 Net Margin > 10% Est. EPS Growth > 5%
ROIC > 10% Past Net Income CAGR > 0%
TTM Financials
Income (TTM)
Revenue$47.35(B)
Gross profit$19.54(B)
EBITDA$12.13(B)
Net income$7.07(B)
Gross margin41.3%
Operating margin18.4%
Net margin14.9%
Shares outstanding370.52(M)
Balance sheet
Total assets$114.23(B)
Current assets$25.61(B)
Total liabilities$59.34(B)
Current liabilities$14.17(B)
Cash & Short-term inv.$6.06(B)
Long-term debt$38.85(B)
Total intangibles$72.34(B)
PP&E$10.58(B)
Cash flow (TTM)
FCF$7.60(B)
CapEx$-1.73(B)
Dividends paid$-673.00(M)
Stock issued$0
Stock repurchased$-4.04(B)
Stock-based comp.$345.00(M)
Debt issued$10.55(B)
Debt repaid$-4.19(B)
